Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

MLA

Franco Trevisani, et al. “Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib.” Clinical and Translational Gastroenterology, vol. 12, Jan. 2021, p. e00286. EBSCOhost, https://doi.org/10.14309/ctg.0000000000000286.

APA

Franco Trevisani, Giulia Magini, Vito Sansone, T. Pressiani, Raffaella Tortora, Rodolfo Sacco, Alessandro Granito, Giovan Giuseppe Di Costanzo, Elena Nardi, Margherita Rimini, Francesco Tovoli, Fabio Piscaglia, Luca Ielasi, & Andrea Casadei-Gardini. (2021). Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib. Clinical and Translational Gastroenterology, 12, e00286. https://doi.org/10.14309/ctg.0000000000000286

Chicago

Franco Trevisani, Giulia Magini, Vito Sansone, T. Pressiani, Raffaella Tortora, Rodolfo Sacco, Alessandro Granito, et al. 2021. “Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib.” Clinical and Translational Gastroenterology 12 (January): e00286. doi:10.14309/ctg.0000000000000286.